ADAR1 Capital Management »

Q/c Technologies shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Q/c Technologies (QCLS) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Q/c Technologies

Tip: Access up to 7 years of quarterly data

All positions including Q/c Technologies held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Q/c Technologies by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $173k 50k 3.45

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Terns Pharmaceuticals Call Option (TERN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Denali Therapeutics (DNLI)
Beam Therapeutics (BEAM)
Zai Lab Adr (ZLAB)
Septerna (SEPN)
Vir Biotechnology (VIR)
Dbv Technologies S A Sponsored Ads (DBVT)

View all positions for ADAR1 Capital Management

Top funds holding Q/c Technologies

Quinn Opportunity Partners
Jane Street
UBS Group
Vanguard Group
ADAR1 Capital Management
Geode Capital Management
Vanguard Capital Management
Virtu Financial
Hrt Financial
Dimensional Fund Advisors
Vanguard Fiduciary Trust
Engineers Gate Manager
Pin Oak Investment Advisors
Sunbelt Securities
Bnp Paribas Arbitrage, Snc

View all funds holding Q/c Technologies